Hotpy, I think most of the pre revenue (especially
bio) company managements grossly exaggerate
their prospects of success. When reality sets in,
the inevitable share price adjustment occurs.
Every biotech I have as a shareholder is guilty of
this. In the case of PAR it is mostly about overly
optimistic timelines, with an eye on the next CR.
It has been said before, but you can only “cry
wolf” so many times before people lose trust
and take what comes out of PR’s mouth as
very unreliable.
- Forums
- ASX - By Stock
- PAR
- PAR. SP
PAR. SP, page-463
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.8¢ |
Change
-0.008(3.33%) |
Mkt cap ! $77.86M |
Open | High | Low | Value | Volume |
23.0¢ | 23.0¢ | 21.8¢ | $59.19K | 265.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 106607 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 6245 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 79427 | 0.220 |
10 | 126312 | 0.215 |
17 | 736102 | 0.210 |
12 | 216589 | 0.205 |
33 | 853969 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 113162 | 6 |
0.230 | 160927 | 4 |
0.235 | 37468 | 3 |
0.240 | 108614 | 5 |
0.250 | 109857 | 5 |
Last trade - 12.20pm 11/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online